FOR NEWSLETTERS Sample Clauses

FOR NEWSLETTERS. Permission covers print and/or electronic versions, provided the AAAS material reproduced as permitted herein remains in situ and is not exploited separately (for example, if permission covers the use of a full text article, the article may not be offered for access or for purchase as a stand-alone unit)
AutoNDA by SimpleDocs

Related to FOR NEWSLETTERS

  • Newsletter ☐ Yes, I would like to receive the newsletter. The monthly newsletter serves to keep you informed about new courses, new teachers, new developments, as well as internal and external events hosted by the GMS, its teachers and its partners. To send the newsletter, we use the mail service provider 'Mailchimp' from the United States. The provider is the Rocket Science Group LLC, 000 Xxxxx Xx Xxxx Ave NE, Suite 5000,Atlanta,GA 30308, USA. They store the mail address, and, where applicable, the first name and the IP address. For further information, please read the data protection agreement. ☐ Yes, I hereby grant my consent. Without the agreement it is not possible to subscribe to the newsletter. I can cancel the agreement at any point in the future. Use of photo, audio and video-material To promote itself and its own events, courses and programs the GMS uses photo material and sometimes audio or video recordings. ☐ Yes, I hereby grant my consent to the GMS to use photos of myself (or of my child) as well as audio/video recordings made of courses, workshops or events for promotional purposes without requiring special permission. I can cancel this agreement any point in the future.

  • Scientific Publications During the Research Program Term, neither Party shall first publish or first present in a public forum the scientific or technical results of any activity performed pursuant to this Agreement without the opportunity for prior review and comment by the other Party. Each Party agrees to provide the other Party with the opportunity to review any proposed abstract, manuscript or scientific presentation (including any verbal presentation) that relates to its activities performed pursuant to this Agreement during the Research Program Term, at least [**] days prior to its intended submission for publication and agrees, upon request, not to submit any such abstract or manuscript for publication until the other Party is given a reasonable period of time up to [**] to secure patent protection for any material in such publication that it believes to be patentable. Both Parties understand that a reasonable commercial strategy may require delay of publication of information or filing of patent applications first with respect to activities performed or results obtained pursuant to this Agreement during the Research Program Term, or not to publish at all if necessary to preserve trade secrets. The Parties agree to review and decide whether to delay publication of such information to permit filing of patent applications. Neither Party shall have the right to publish or present any Confidential Information of the other Party, except as provided in Section 9.2. After the Research Program Term, each Party and its Affiliates may publish or present results, data or scientific findings of any of their activities without the prior review of the other Party, provided that such publication or presentation does not disclose any of the other Party’s Confidential Information. Nothing contained in this Section 9.3 shall prohibit the inclusion of information necessary for a patent application; provided that the non-filing Party is given a reasonable opportunity to review the information to be included prior to submission of such patent application in accordance with Section 8.2. Nothing contained in this Section 9.3 shall prohibit either Party from disclosing the results, data or scientific findings of any activity performed by the other Party or its Affiliates pursuant to this Agreement without prior review and prior written consent of the other Party, where required, as reasonably determined by the disclosing Party’s legal counsel, by applicable law; provided that if a Party is required by law to make any such disclosure, to the extent it may legally do so, it will give reasonable advance notice to the other Party of such disclosure and will use its reasonable efforts to secure confidential treatment of such information prior to its disclosure (whether through protective orders or otherwise).

  • Publications and Presentations (a) Corvus may publish or present the final results of the Study (in accordance with this Section 8.2); provided that Corvus gives Genentech an opportunity to review and provide comments in accordance with subsection (b). (b) In the event that either Party (for purposes of this Section, the “Publishing Party”) wishes to publish or present any Study Data or Sample Data, the Publishing Party shall submit to the other Party (for purposes of this Section, the “Reviewing Party”) all materials related to the proposed publication or presentation (including posters, abstracts, manuscripts and written descriptions of oral presentations) at least [***] days (or [***], in the case of abstracts) prior to the date of submission for publication or the date of presentation, whichever is earlier, of any of such submitted materials. The Reviewing Party shall review such submitted materials and respond to the Publishing Party as soon as reasonably possible, but in any case within [***] (or [***], in the case of abstracts) of receipt thereof. The Publishing Party will be permitted to publish or present such Study Data or Sample Data, but shall give reasonable consideration to any request by the Reviewing Party; provided, however, at the request of the Reviewing Party, the Publishing Party shall (i) delete from such proposed publication or presentation Confidential Information of the Reviewing Party (including Sample Data), provided that the Publishing Party shall have no obligation to delete any Study Data; and/or (ii) if such proposed publication or presentation contains patentable subject matter owned solely or jointly by the Reviewing Party, delay such proposed publication or presentation, for [***], to permit the Reviewing Party to prepare and file a patent application. The Publishing Party shall comply with all applicable requirements regarding disclosure of industry support (financial or otherwise) in connection with any publications and presentations. For clarity, the provisions of this Section 8.2 only apply to publications or presentations of Study Data or Sample Data and do not apply to any other publications or presentations by a Party, including with respect to results from such Party’s development activities outside of the Study. (c) Authorship of publications or presentations of final results of the Study and/or any Study Data or Sample Data shall be determined in accordance with appropriate scientific and academic standards and customs.

  • Investment Analysis and Commentary The Subadviser will provide quarterly performance analysis and market commentary (the “Investment Report”) during the term of this Agreement. The Investment Reports are due within 10 days after the end of each quarter. In addition, interim Investment Reports shall be issued at such times as may be mutually agreed upon by the Adviser and Subadviser; provided however, that any such interim Investment Report will be due within 10 days of the end of the month in which such agreement is reached between the Adviser and Subadviser. The subject of each Investment Report shall be mutually agreed upon. The Adviser is freely able to publicly distribute the Investment Report.

  • Publications Neither Party shall publicly present or publish results of studies carried out under this Agreement (each such presentation or publication a “Publication”) without the opportunity for prior review by the other Party, except to the extent otherwise required by Applicable Law, in which case Section 12.3 shall apply with respect to disclosures required by the SEC and/or for regulatory filings. The submitting Party shall provide the other Party the opportunity to review any proposed Publication at least thirty (30) days prior to the earlier of its presentation or intended submission for publication. The submitting Party agrees, upon request by the other Party, not to submit or present any Publication until the other Party has had thirty (30) days to comment on any material in such Publication. The submitting Party shall consider the comments of the other Party in good faith, but will retain the sole authority to submit the manuscript for Publication; provided that the submitting Party agrees to delay such Publication as necessary to enable the Parties to file a Patent if such Publication might adversely affect such Patent. The submitting Party shall provide the other Party a copy of the Publication at the time of the submission or presentation. Notwithstanding the foregoing, BMS shall not have the right to publish or present Ambrx’s Confidential Information without Ambrx’s prior written consent, and Ambrx shall not have the right to publish or present BMS’ Confidential Information without BMS’ prior written consent. Each Party agrees to acknowledge the contributions of the other Party, and the employees of the other Party, in all publications as scientifically appropriate. This Section 12.4 shall not limit and shall be subject to Section 12.5. Nothing contained in this Section 12.4 shall prohibit the inclusion of information in a patent application claiming, and in furtherance of, the manufacture, use, sale or formulation of a Compound, provided that the non-filing Party is given a reasonable opportunity to review, comment upon and/or approve the information to be included prior to submission of such patent application, where and to the extent required by Article 9 hereof. Notwithstanding the foregoing, the Parties recognize that independent investigators have been engaged, and will be engaged in the future, to conduct Clinical Trials of Compounds and Products. The Parties recognize that such investigators operate in an academic environment and may release information regarding such studies in a manner consistent with academic standards; provided that each Party will use reasonable efforts to prevent publication prior to the filing of relevant patent applications and to ensure that no Confidential Information of either Party is disclosed.

  • Bibliography Xxxx, X. & Xxxxxxxx, X. A New Reference Grammar of Modern Spanish. London: Xxxxxx Xxxxxx, 1989 (varias eds.). Xxxxx Xxxxxxx, X. Xxxxxx y escribir correctamente: gramática normativa del español actual. Madrid: Arco/Libros. 2006. Real Academia Española, Asociación de Academias de la Lengua Española. Nueva gramática de la lengua española: Manual. Madrid: Espasa, 2010. Xxxxxxx, M.S. Spanish/English Contrasts: a Course in Spanish Linguistics. Georgetown University Press. 2002. xxx.xxx.xxxxxxxxx.xx/aula/didactired/didactiteca (The Instituto Xxxxxxxxx Didactics Library) xxx.xxx.xxxxxxxxx.xx/aula/pasatiempos (Interactive didactic activities aimed at students of Spanish) xxx.xxx.xxxxxxxxx.xx/lengua/refranero (A selection of proverbs and proverbial phrases in Spanish with their equivalents in a range of other languages.) xxx.xxx.xx (Diccionario de la Real Academia de la Lengua Española) xxx.xxxxxxxxxxxxx.xxx (Diccionario inglés-español-inglés) Final Grades will be calculated with the following distributive basis in mind: - Regular class attendance: 10% - Classwork undertaken: 15% - Active participation in class sessions: 25% - The successful completion of an assignment based on the prose work, Xxxxxxxxx xx Xxxxxx: 15% - A final exam which will involve testing all Course-content: 35% - Grading on a scale of 10 as maximum: Fail (0-4’9); Pass (5-6’9); Very Good (7- 8’9); Excellent (9); With Distinction (10). Course FA-37 PAINTING IN LITERARY SEVILLE (45 class hours) Lecturer: Xxxx Xxxxx (xxxxxxxxxxxxxxxx@xxxxx.xxx) Substitute Lecturer: Xxxx Xxxxxx Xxxx (xxxx@xxxxxxxxx.xxx)

  • Links If The Services are made available through the Internet, the Financial Institution’s website may provide links to other websites, including those of Third Parties who may also provide services to You. You acknowledge that all those other websites and Third Party services are independent from the Financial Institution’s and may be subject to separate agreements that govern their use. The Financial Institution and Central 1 have no liability for those other websites or their contents or the use of Third Party services. Links are provided for convenience only, and You assume all risk resulting from accessing or using such other websites or Third Party services.

  • Directory Publication Nothing in this Agreement shall require Verizon to publish a directory where it would not otherwise do so.

  • Workshops During the month of September or October of each year during the term of this Agreement, there shall be held at each University a workshop for Department Chairs at which will be discussed their roles and responsibilities as such. Representatives of the University, at its election, and representatives of the Association, at its election, shall be permitted to participate jointly in such workshop.

  • RESEARCH AND PUBLICATION 29 CONTRACTOR shall not utilize information and/or data received from COUNTY, or arising out 30 of, or developed, as a result of this Agreement for the purpose of personal or professional research, or 31 for publication. 32

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!